ES2818569T3 - Métodos para la recopilación, estabilización y conservación de muestras - Google Patents
Métodos para la recopilación, estabilización y conservación de muestras Download PDFInfo
- Publication number
- ES2818569T3 ES2818569T3 ES16845220T ES16845220T ES2818569T3 ES 2818569 T3 ES2818569 T3 ES 2818569T3 ES 16845220 T ES16845220 T ES 16845220T ES 16845220 T ES16845220 T ES 16845220T ES 2818569 T3 ES2818569 T3 ES 2818569T3
- Authority
- ES
- Spain
- Prior art keywords
- less
- sample
- stabilization
- matrix
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000006641 stabilisation Effects 0.000 title claims abstract description 235
- 238000011105 stabilization Methods 0.000 title claims abstract description 235
- 238000000034 method Methods 0.000 title claims abstract description 163
- 238000004321 preservation Methods 0.000 title description 3
- 239000000523 sample Substances 0.000 claims abstract description 368
- 239000011159 matrix material Substances 0.000 claims abstract description 255
- 239000012472 biological sample Substances 0.000 claims abstract description 54
- 230000000087 stabilizing effect Effects 0.000 claims abstract description 50
- 238000005070 sampling Methods 0.000 claims abstract description 47
- 238000000926 separation method Methods 0.000 claims description 87
- 210000004369 blood Anatomy 0.000 claims description 74
- 239000008280 blood Substances 0.000 claims description 74
- 102000004169 proteins and genes Human genes 0.000 claims description 74
- 108090000623 proteins and genes Proteins 0.000 claims description 73
- 239000003153 chemical reaction reagent Substances 0.000 claims description 62
- 239000000463 material Substances 0.000 claims description 34
- 229920002678 cellulose Polymers 0.000 claims description 16
- 239000001913 cellulose Substances 0.000 claims description 16
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 claims description 13
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 229920002301 cellulose acetate Polymers 0.000 claims description 9
- 239000011152 fibreglass Substances 0.000 claims description 9
- 230000036571 hydration Effects 0.000 claims description 8
- 238000006703 hydration reaction Methods 0.000 claims description 8
- 230000002269 spontaneous effect Effects 0.000 claims description 7
- 150000004043 trisaccharides Chemical class 0.000 claims description 6
- 239000002250 absorbent Substances 0.000 claims description 5
- 230000002745 absorbent Effects 0.000 claims description 5
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 2
- DBTMGCOVALSLOR-VXXRBQRTSA-N alpha-D-Glcp-(1->3)-alpha-D-Glcp-(1->3)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VXXRBQRTSA-N 0.000 claims description 2
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 claims description 2
- FGPATWVHNYVVEE-SKPZHCOCSA-N maltotriulose Chemical compound OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 FGPATWVHNYVVEE-SKPZHCOCSA-N 0.000 claims description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 claims description 2
- FBJQEBRMDXPWNX-FYHZSNTMSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-FYHZSNTMSA-N 0.000 claims 1
- 239000007787 solid Substances 0.000 description 124
- 102000039446 nucleic acids Human genes 0.000 description 123
- 108020004707 nucleic acids Proteins 0.000 description 123
- 150000007523 nucleic acids Chemical class 0.000 description 123
- 239000000758 substrate Substances 0.000 description 120
- 108020004414 DNA Proteins 0.000 description 87
- 239000012528 membrane Substances 0.000 description 86
- 235000018102 proteins Nutrition 0.000 description 70
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 64
- 239000012149 elution buffer Substances 0.000 description 55
- 239000000872 buffer Substances 0.000 description 53
- 239000000126 substance Substances 0.000 description 45
- 239000012148 binding buffer Substances 0.000 description 33
- 238000012360 testing method Methods 0.000 description 33
- 238000009739 binding Methods 0.000 description 29
- 239000011534 wash buffer Substances 0.000 description 29
- 238000004458 analytical method Methods 0.000 description 28
- 210000002381 plasma Anatomy 0.000 description 28
- 230000027455 binding Effects 0.000 description 26
- 238000010828 elution Methods 0.000 description 26
- 238000001914 filtration Methods 0.000 description 25
- 235000002639 sodium chloride Nutrition 0.000 description 25
- 239000012139 lysis buffer Substances 0.000 description 24
- 238000003860 storage Methods 0.000 description 24
- 102000053602 DNA Human genes 0.000 description 23
- 239000000203 mixture Substances 0.000 description 23
- 150000003839 salts Chemical class 0.000 description 21
- 238000012546 transfer Methods 0.000 description 21
- 239000004094 surface-active agent Substances 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 18
- 238000000605 extraction Methods 0.000 description 17
- -1 but not limited to Substances 0.000 description 15
- 239000003960 organic solvent Substances 0.000 description 14
- 238000012545 processing Methods 0.000 description 14
- 108091028043 Nucleic acid sequence Proteins 0.000 description 13
- 108020004682 Single-Stranded DNA Proteins 0.000 description 13
- 239000003398 denaturant Substances 0.000 description 12
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 12
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 12
- 239000011148 porous material Substances 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 229920002873 Polyethylenimine Polymers 0.000 description 11
- 238000002405 diagnostic procedure Methods 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 239000012530 fluid Substances 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 230000003196 chaotropic effect Effects 0.000 description 10
- 230000009089 cytolysis Effects 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 102000003960 Ligases Human genes 0.000 description 9
- 108090000364 Ligases Proteins 0.000 description 9
- 239000012620 biological material Substances 0.000 description 9
- 239000003550 marker Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 229920001213 Polysorbate 20 Polymers 0.000 description 8
- 238000013019 agitation Methods 0.000 description 8
- 239000003599 detergent Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 8
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 7
- 230000003321 amplification Effects 0.000 description 7
- 239000004005 microsphere Substances 0.000 description 7
- 229920005862 polyol Polymers 0.000 description 7
- 150000003077 polyols Chemical class 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 6
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 6
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 239000004695 Polyether sulfone Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000012928 buffer substance Substances 0.000 description 6
- 239000003638 chemical reducing agent Substances 0.000 description 6
- 230000037368 penetrate the skin Effects 0.000 description 6
- 229920006393 polyether sulfone Polymers 0.000 description 6
- 229920000136 polysorbate Polymers 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 5
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 5
- 239000000020 Nitrocellulose Substances 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 229920001220 nitrocellulos Polymers 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 229920000515 polycarbonate Polymers 0.000 description 5
- 239000004417 polycarbonate Substances 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 239000003161 ribonuclease inhibitor Substances 0.000 description 5
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- NYEZZYQZRQDLEH-UHFFFAOYSA-N 2-ethyl-4,5-dihydro-1,3-oxazole Chemical compound CCC1=NCCO1 NYEZZYQZRQDLEH-UHFFFAOYSA-N 0.000 description 4
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 229940123457 Free radical scavenger Drugs 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 4
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000003491 array Methods 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 239000003365 glass fiber Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229920002113 octoxynol Polymers 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000002516 radical scavenger Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000003656 tris buffered saline Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 102000006382 Ribonucleases Human genes 0.000 description 3
- 108010083644 Ribonucleases Proteins 0.000 description 3
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000010241 blood sampling Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 235000009518 sodium iodide Nutrition 0.000 description 3
- 239000011343 solid material Substances 0.000 description 3
- 150000003567 thiocyanates Chemical class 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- AJDONJVWDSZZQF-UHFFFAOYSA-N 1-(2,4,4-trimethylpentan-2-yl)-4-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]benzene Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OC1=CC=C(C(C)(C)CC(C)(C)C)C=C1 AJDONJVWDSZZQF-UHFFFAOYSA-N 0.000 description 2
- IEORSVTYLWZQJQ-UHFFFAOYSA-N 2-(2-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=CC=C1OCCO IEORSVTYLWZQJQ-UHFFFAOYSA-N 0.000 description 2
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
- JTNCEQNHURODLX-UHFFFAOYSA-N 2-phenylethanimidamide Chemical compound NC(=N)CC1=CC=CC=C1 JTNCEQNHURODLX-UHFFFAOYSA-N 0.000 description 2
- RZQXOGQSPBYUKH-UHFFFAOYSA-N 3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound OCC(CO)(CO)NCC(O)CS(O)(=O)=O RZQXOGQSPBYUKH-UHFFFAOYSA-N 0.000 description 2
- XWNSFEAWWGGSKJ-UHFFFAOYSA-N 4-acetyl-4-methylheptanedinitrile Chemical compound N#CCCC(C)(C(=O)C)CCC#N XWNSFEAWWGGSKJ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 108700016232 Arg(2)-Sar(4)- dermorphin (1-4) Proteins 0.000 description 2
- 108020000946 Bacterial DNA Proteins 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- PCDQPRRSZKQHHS-CCXZUQQUSA-N Cytarabine Triphosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-CCXZUQQUSA-N 0.000 description 2
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical group C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000007993 MOPS buffer Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 239000004153 Potassium bromate Substances 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical group O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 239000007997 Tricine buffer Substances 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000007998 bicine buffer Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000008711 chromosomal rearrangement Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 2
- OGGXGZAMXPVRFZ-UHFFFAOYSA-M dimethylarsinate Chemical compound C[As](C)([O-])=O OGGXGZAMXPVRFZ-UHFFFAOYSA-M 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 229960000789 guanidine hydrochloride Drugs 0.000 description 2
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000006193 liquid solution Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 229920000847 nonoxynol Polymers 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229940066429 octoxynol Drugs 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 210000004180 plasmocyte Anatomy 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229940068965 polysorbates Drugs 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 2
- 229940094037 potassium bromate Drugs 0.000 description 2
- 235000019396 potassium bromate Nutrition 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001012 protector Effects 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 2
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 2
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- OGMADIBCHLQMIP-UHFFFAOYSA-N 2-aminoethanethiol;hydron;chloride Chemical compound Cl.NCCS OGMADIBCHLQMIP-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108091005504 Asparagine peptide lyases Proteins 0.000 description 1
- 108091005502 Aspartic proteases Proteins 0.000 description 1
- 102000035101 Aspartic proteases Human genes 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 230000005653 Brownian motion process Effects 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 101000925646 Enterobacteria phage T4 Endolysin Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108091005503 Glutamic proteases Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- YNLCVAQJIKOXER-UHFFFAOYSA-N N-[tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid Chemical compound OCC(CO)(CO)NCCCS(O)(=O)=O YNLCVAQJIKOXER-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 1
- 229920002560 Polyethylene Glycol 3000 Polymers 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920000265 Polyparaphenylene Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 239000012162 RNA isolation reagent Substances 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 108091005501 Threonine proteases Proteins 0.000 description 1
- 102000035100 Threonine proteases Human genes 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- PGAVKCOVUIYSFO-UHFFFAOYSA-N [[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000006154 adenylylation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 238000005537 brownian motion Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 108091092259 cell-free RNA Proteins 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940096384 chicken egg white lysozyme Drugs 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- JIONSDIFUGDYLD-UHFFFAOYSA-N diaminomethylideneazanium;phenol;thiocyanate Chemical compound [S-]C#N.NC([NH3+])=N.OC1=CC=CC=C1 JIONSDIFUGDYLD-UHFFFAOYSA-N 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- WQABCVAJNWAXTE-UHFFFAOYSA-N dimercaprol Chemical compound OCC(S)CS WQABCVAJNWAXTE-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000011013 endotoxin removal Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000012632 extractable Substances 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 238000005558 fluorometry Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000012125 lateral flow test Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 1
- 229910001486 lithium perchlorate Inorganic materials 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000001483 monosaccharide substituent group Chemical group 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000000956 solid--liquid extraction Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical class OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150977—Arrays of piercing elements for simultaneous piercing
- A61B5/150984—Microneedles or microblades
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
- C12M1/3446—Photometry, spectroscopy, laser technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150053—Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
- A61B5/150061—Means for enhancing collection
- A61B5/150083—Means for enhancing collection by vibration, e.g. ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150053—Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
- A61B5/150061—Means for enhancing collection
- A61B5/150099—Means for enhancing collection by negative pressure, other than vacuum extraction into a syringe by pulling on the piston rod or into pre-evacuated tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150389—Hollow piercing elements, e.g. canulas, needles, for piercing the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150503—Single-ended needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150755—Blood sample preparation for further analysis, e.g. by separating blood components or by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150763—Details with identification means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150763—Details with identification means
- A61B5/150786—Optical identification systems, e.g. bar codes, colour codes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150763—Details with identification means
- A61B5/150793—Electrical or magnetic identification means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15103—Piercing procedure
- A61B5/15107—Piercing being assisted by a triggering mechanism
- A61B5/15113—Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15142—Devices intended for single use, i.e. disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15142—Devices intended for single use, i.e. disposable
- A61B5/15144—Devices intended for single use, i.e. disposable comprising driving means, e.g. a spring, for retracting the piercing unit into the housing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
- B01D63/08—Flat membrane modules
- B01D63/087—Single membrane modules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/24—Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/08—Flask, bottle or test tube
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2319/00—Membrane assemblies within one housing
- B01D2319/02—Elements in series
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2319/00—Membrane assemblies within one housing
- B01D2319/06—Use of membranes of different materials or properties within one module
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Sustainable Development (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Clinical Laboratory Science (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Pharmacology & Pharmacy (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562216312P | 2015-09-09 | 2015-09-09 | |
| US201562260172P | 2015-11-25 | 2015-11-25 | |
| US201662367056P | 2016-07-26 | 2016-07-26 | |
| US201662368817P | 2016-07-29 | 2016-07-29 | |
| PCT/US2016/051157 WO2017044887A1 (en) | 2015-09-09 | 2016-09-09 | Systems, methods, and devices for sample collection, stabilization and preservation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2818569T3 true ES2818569T3 (es) | 2021-04-13 |
Family
ID=57234675
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16845220T Active ES2818569T3 (es) | 2015-09-09 | 2016-09-09 | Métodos para la recopilación, estabilización y conservación de muestras |
| ES22150560T Active ES2963004T3 (es) | 2015-09-09 | 2016-09-09 | Dispositivos para la recopilación, estabilización y conservación de muestras |
| ES20175443T Active ES2912965T3 (es) | 2015-09-09 | 2016-09-09 | Dispositivos para la recopilación, estabilización y conservación de muestras |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES22150560T Active ES2963004T3 (es) | 2015-09-09 | 2016-09-09 | Dispositivos para la recopilación, estabilización y conservación de muestras |
| ES20175443T Active ES2912965T3 (es) | 2015-09-09 | 2016-09-09 | Dispositivos para la recopilación, estabilización y conservación de muestras |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11266337B2 (https=) |
| EP (4) | EP3347448B1 (https=) |
| JP (4) | JP7142569B2 (https=) |
| CN (2) | CN108473932B (https=) |
| ES (3) | ES2818569T3 (https=) |
| FI (1) | FI4035762T3 (https=) |
| GB (2) | GB2547062B (https=) |
| HK (1) | HK1258397A1 (https=) |
| WO (1) | WO2017044887A1 (https=) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012018486A2 (en) | 2010-07-26 | 2012-02-09 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
| US9295417B2 (en) | 2011-04-29 | 2016-03-29 | Seventh Sense Biosystems, Inc. | Systems and methods for collecting fluid from a subject |
| CN102405018B (zh) | 2009-03-02 | 2014-11-19 | 第七感生物系统有限公司 | 与血液取样相关联的技术和装置 |
| EP2954916A3 (en) * | 2010-08-13 | 2016-04-20 | Seventh Sense Biosystems, Inc. | Clinical and/or consumer techniques and devices |
| WO2012021801A2 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
| EP2992827B1 (en) | 2010-11-09 | 2017-04-19 | Seventh Sense Biosystems, Inc. | Systems and interfaces for blood sampling |
| KR20140034200A (ko) | 2011-04-29 | 2014-03-19 | 세븐쓰 센스 바이오시스템즈, 인크. | 혈액 스폿들 또는 다른 신체 유체들을 수집 및/또는 조작하기 위한 시스템들 및 방법들 |
| US20130158468A1 (en) | 2011-12-19 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving material with respect to a subject surface |
| CN103874460B (zh) | 2011-04-29 | 2016-06-22 | 第七感生物系统有限公司 | 一种用于从受验者的皮肤接收血液或其它物质的装置 |
| CN108473932B (zh) * | 2015-09-09 | 2022-07-15 | 集联健康有限公司 | 用于样品收集、稳定化和保存的系统、方法和装置 |
| WO2018081161A1 (en) * | 2016-10-24 | 2018-05-03 | Biomatrica, Inc. | Stabilization of nucleic acids on paper |
| TWI882519B (zh) | 2017-01-10 | 2025-05-01 | 美商集聯健康有限公司 | 用於收集和儲存來自受試者之血液的裝置 |
| US11168323B2 (en) | 2017-06-01 | 2021-11-09 | Nantomics Llc | DNA stabilization of RNA |
| KR20200083461A (ko) * | 2017-09-26 | 2020-07-08 | 주노 다이어그노스틱스, 인크. | 바이오마커 분석을 위한 디바이스, 시스템 및 방법 |
| AU2018355575A1 (en) * | 2017-10-27 | 2020-05-21 | Juno Diagnostics, Inc. | Devices, systems and methods for ultra-low volume liquid biopsy |
| US10758867B2 (en) | 2017-11-30 | 2020-09-01 | Wellsim Biomedical Technologies, Inc | Isolation device and isolation method |
| GB201819134D0 (en) * | 2018-11-23 | 2019-01-09 | Cancer Research Tech Ltd | Improvements in variant detection |
| US12462935B2 (en) | 2018-03-30 | 2025-11-04 | Nucleix Ltd. | Deep learning-based methods, devices, and systems for prenatal testing |
| EP3923808B1 (en) * | 2019-02-14 | 2023-06-07 | Becton, Dickinson and Company | Capillary collector with rotatable connection |
| WO2021046343A1 (en) * | 2019-09-06 | 2021-03-11 | Teleflex Medical Incorporated | Lysing solution for real-time determining the identification and antibiotic resistance of pathogenic microorganisms |
| US20220251650A1 (en) * | 2019-09-23 | 2022-08-11 | Gateway Genomics, Llc | Methods, compositions, and kits for determining the sex of a fetus |
| US20230203586A1 (en) * | 2020-05-29 | 2023-06-29 | The Rockefeller University | Method and system for rna isolation from self-collected and small volume samples |
| KR20230069096A (ko) * | 2020-09-18 | 2023-05-18 | 프로콤큐어 바이오테크 게엠베하 | 타액 샘플 수집용 키트 |
| CN112280661A (zh) * | 2020-10-15 | 2021-01-29 | 西咸新区国睿一诺药物安全评价研究有限公司 | 一种胚胎卵黄囊吸收毒性试验用的流水式测试系统 |
| US20220133191A1 (en) * | 2020-11-04 | 2022-05-05 | Verily Life Sciences Llc | Optical methods to modulate local blood perfusion at the skin |
| WO2022192295A1 (en) * | 2021-03-08 | 2022-09-15 | Michael Wohl | Kits and methods for collecting and transporting a pathogen |
| CN112760360B (zh) * | 2021-03-22 | 2023-12-19 | 洛阳赛奥生物工程技术有限公司 | 一种rna保护剂及其应用 |
| US12053284B2 (en) | 2021-11-08 | 2024-08-06 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US11964121B2 (en) | 2021-10-13 | 2024-04-23 | Satio, Inc. | Mono dose dermal patch for pharmaceutical delivery |
| US11452474B1 (en) | 2021-04-14 | 2022-09-27 | Satio, Inc. | Dual lever dermal patch system |
| US12048543B2 (en) | 2021-11-08 | 2024-07-30 | Satio, Inc. | Dermal patch for collecting a physiological sample with removable vial |
| US12023156B2 (en) | 2021-10-13 | 2024-07-02 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US11877848B2 (en) | 2021-11-08 | 2024-01-23 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12214346B2 (en) | 2021-10-13 | 2025-02-04 | Satio, Inc. | Dermal patch with a diagnostic test strip |
| US12178979B2 (en) | 2021-10-13 | 2024-12-31 | Satio, Inc. | Dermal patch for delivering a pharmaceutical |
| CN113349774B (zh) * | 2021-06-07 | 2022-06-24 | 孟斯琴 | 一种心内科临床检验采血用固定装置 |
| CN113462750B (zh) * | 2021-06-29 | 2024-08-27 | 浙江峻山生物科技有限公司 | 一种提高病毒核酸检测灵敏度的样本保存液及其制备方法 |
| EP4405655A4 (en) * | 2021-09-23 | 2025-11-19 | Drawbridge Health Inc | SAMPLE COLLECTION SYSTEMS AND METHODS |
| MX2024004522A (es) * | 2021-10-15 | 2024-05-08 | Becton Dickinson Co | Mezcla con aditivos para la recogida de muestras de sangre. |
| CN114426924B (zh) * | 2022-01-26 | 2024-06-04 | 天宫精准医疗技术(上海)有限公司 | 一种多功能干细胞组织采集装置 |
| US11957465B2 (en) | 2022-08-23 | 2024-04-16 | Reddrop Dx, Inc. | Accelerated ergonomic collection of capillary blood |
| KR20250056189A (ko) | 2022-08-24 | 2025-04-25 | 가부시끼가이샤아사히폴리슬라이더 | 채혈 디바이스 및 채혈 저류 디바이스 |
| CN115628951A (zh) * | 2022-10-18 | 2023-01-20 | 南京火眼金睛安全科技有限公司 | 一种用于痕量毒品检测的人体毛发裂解液及其应用 |
| CN117169519B (zh) * | 2023-10-26 | 2024-01-30 | 艾康生物技术(杭州)有限公司 | 用于检测样本中tt3和/或tt4的解离剂和试剂盒 |
| SE548123C2 (en) * | 2023-11-08 | 2026-03-31 | Sequrna Ab | Device for dry storage of biological samples, conserving RNA from degradation and use of such devices |
| CN120591257B (zh) * | 2025-08-07 | 2025-12-12 | 上海金福康制药工程技术有限公司 | 一种cfDNA提取试剂盒及提取方法 |
Family Cites Families (431)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE542544A (https=) | 1954-11-04 | |||
| US3070486A (en) | 1958-12-15 | 1962-12-25 | Ohio Commw Eng Co | Cigarette paper products comprising water insoluble dextran |
| US3227075A (en) | 1961-04-04 | 1966-01-04 | Fitchburg Paper | Planographic printing plates |
| US3300474A (en) | 1964-02-12 | 1967-01-24 | Pharmacia Ab | Sucrose ether copolymerizates |
| CA928198A (en) | 1968-07-15 | 1973-06-12 | Boehringer Mannheim G.M.B.H. | Storable blood and serum samples and a process for their preparation |
| CH522395A (fr) | 1968-07-26 | 1972-05-15 | Micromedic Systems Inc | Eprouvette destinée à la prise de sang percutanée et digitale |
| AU2919171A (en) | 1970-05-27 | 1972-11-30 | Pharmacia Ab | A method for carrying out tests, a reagent andan additive for carrying out the method |
| JPS5319092A (en) | 1976-11-08 | 1978-02-21 | Shionogi Seiyaku Kk | Composite for liver desease detection |
| CH620300A5 (en) | 1977-04-29 | 1980-11-14 | Miles Lab | Reactive strip for analysis |
| US4257426A (en) | 1979-06-22 | 1981-03-24 | Marquest Medical Products, Inc. | Vacuum assisted anti-coagulant syringe device for taking blood samples |
| US4540506A (en) | 1983-04-15 | 1985-09-10 | Genex Corporation | Composition for cleaning drains clogged with deposits containing hair |
| CA1255197A (en) | 1984-09-24 | 1989-06-06 | Joseph L. Orlik | Leukocyte differentiation composition and method |
| US5173422A (en) | 1986-08-22 | 1992-12-22 | Miles Inc. | Monoclonal antibodies specific for human glycoalbumin |
| SE462464B (sv) | 1987-01-14 | 1990-07-02 | Broden Bengt Inge | Utrustning foer provtagning paa patienter |
| JP2728757B2 (ja) | 1988-02-11 | 1998-03-18 | キューノ，インコーポレーテッド | 変性多糖支持体の親和性マトリックス |
| JPH01291164A (ja) | 1988-05-19 | 1989-11-22 | Fujirebio Inc | 標準瀘紙用組成物 |
| US5807527A (en) | 1991-05-29 | 1998-09-15 | Flinders Technologies Pty. Ltd. | Solid medium and method for DNA storage |
| US5972386A (en) | 1995-12-19 | 1999-10-26 | Flinders Technologies Pty, Ltd. | Dry solid medium for storage and analysis of genetic material |
| US5756126A (en) | 1991-05-29 | 1998-05-26 | Flinders Technologies Pty. Ltd. | Dry solid medium for storage and analysis of genetic material |
| US6627226B2 (en) | 1988-10-05 | 2003-09-30 | Whatman, Inc. | Dry solid medium for storage and analysis of genetic material |
| US5496562A (en) | 1988-10-05 | 1996-03-05 | Flinders Technologies Pty Ltd | Solid medium and method for DNA storage |
| US5985327A (en) | 1988-10-05 | 1999-11-16 | Flinders Technologies Pty. Ltd. | Solid medium and method for DNA storage |
| US5252489A (en) | 1989-01-17 | 1993-10-12 | Macri James N | Down syndrome screening method utilizing dried blood samples |
| US5234809A (en) | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
| US5054499A (en) | 1989-03-27 | 1991-10-08 | Swierczek Remi D | Disposable skin perforator and blood testing device |
| ATE118615T1 (de) | 1989-04-07 | 1995-03-15 | Abbott Lab | Verfahren und vorrichtung zur trennung von plasma oder von serum aus blut. |
| US5141850A (en) | 1990-02-07 | 1992-08-25 | Hygeia Sciences, Inc. | Porous strip form assay device method |
| GB9010742D0 (en) | 1990-05-14 | 1990-07-04 | Quadrant Bioresources Ltd | Stabilization of biological macromolecular substances |
| JP2572823Y2 (ja) | 1992-02-13 | 1998-05-25 | 株式会社アドバンス | 簡易採血器 |
| US5494646A (en) | 1993-04-14 | 1996-02-27 | Seymour; Eugene H. | Sampling device and sample adequacy system |
| JP3494183B2 (ja) | 1993-08-10 | 2004-02-03 | 株式会社アドバンス | 簡易採血装置 |
| US5756362A (en) | 1993-10-12 | 1998-05-26 | Cornell Research Foundation, Inc. | Liposome-enhanced immunoaggregation assay and test device |
| CA2127605A1 (en) | 1993-12-23 | 1995-06-24 | Peter J. Degen | Affinity separation method |
| ATE295223T1 (de) | 1994-03-04 | 2005-05-15 | Pall Corp | Gross-porige membranen aus synthetischen polymeren |
| US6277281B1 (en) | 1994-03-04 | 2001-08-21 | Usf Filtration And Separations Group Inc. | Large pore synthetic polymer membranes |
| US5593824A (en) | 1994-09-02 | 1997-01-14 | Pharmacia Biotech, Inc. | Biological reagent spheres |
| SE9404468D0 (sv) | 1994-12-22 | 1994-12-22 | Astra Ab | Powder formulations |
| US5636640A (en) | 1995-02-06 | 1997-06-10 | Volunteers For Medical Engineering | Liquid sampling and test apparatus |
| US5725774A (en) | 1995-04-07 | 1998-03-10 | Lxn Corp. | Whole blood separation method and devices using the same |
| AU706447B2 (en) | 1995-04-13 | 1999-06-17 | Advanced Cytometrix, Inc. | Aspiration needle apparatus incorporating its own vacuum and method and adapter for use therewith |
| CA2222641C (en) | 1995-06-07 | 2006-10-17 | Memtec America Corporation | Microfiltration membranes having high pore density and mixed isotropic and anisotropic structure |
| WO1996039813A1 (en) | 1995-06-07 | 1996-12-19 | Flinders Technologies Pty. Ltd. | Dry solid medium for storage and analysis of genetic material |
| DE69628007T2 (de) * | 1995-06-07 | 2003-11-27 | Elan Drug Delivery Ltd., Ruddington | Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen |
| US5906742A (en) | 1995-07-05 | 1999-05-25 | Usf Filtration And Separations Group Inc. | Microfiltration membranes having high pore density and mixed isotropic and anisotropic structure |
| US5981218A (en) | 1995-08-09 | 1999-11-09 | Bristol-Myers Squibb Company | Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis and encoded polypeptides |
| US5804684A (en) | 1995-08-24 | 1998-09-08 | The Theobald Smith Research Institute, Inc. | Method for isolating nucleic acids |
| DE29514084U1 (de) | 1995-09-01 | 1995-11-02 | Biosafe Diagnostics Corp., Lincolnshire, Ill. | Blutentnahme- und -testvorrichtung |
| US5662127A (en) | 1996-01-17 | 1997-09-02 | Bio-Plas, Inc. | Self-contained blood withdrawal apparatus and method |
| US7235056B2 (en) | 1996-05-17 | 2007-06-26 | Amira Medical | Body fluid sampling device and methods of use |
| US6340354B1 (en) | 1996-05-17 | 2002-01-22 | Christopher L Rambin | Automated compulsory blood extraction system |
| US7828749B2 (en) | 1996-05-17 | 2010-11-09 | Roche Diagnostics Operations, Inc. | Blood and interstitial fluid sampling device |
| US6332871B1 (en) | 1996-05-17 | 2001-12-25 | Amira Medical | Blood and interstitial fluid sampling device |
| US7666150B2 (en) | 1996-05-17 | 2010-02-23 | Roche Diagnostics Operations, Inc. | Blood and interstitial fluid sampling device |
| US6004278A (en) | 1996-12-05 | 1999-12-21 | Mdc Investment Holdings, Inc. | Fluid collection device with retractable needle |
| WO1998024493A1 (en) | 1996-12-05 | 1998-06-11 | Mdc Investment Holdings, Inc. | Fluid collection device with retractable needle |
| US6071251A (en) | 1996-12-06 | 2000-06-06 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
| US6063039A (en) | 1996-12-06 | 2000-05-16 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
| US6045899A (en) | 1996-12-12 | 2000-04-04 | Usf Filtration & Separations Group, Inc. | Highly assymetric, hydrophilic, microfiltration membranes having large pore diameters |
| JPH10179722A (ja) | 1996-12-25 | 1998-07-07 | Sumitomo Bakelite Co Ltd | 表面処理 |
| US5939259A (en) | 1997-04-09 | 1999-08-17 | Schleicher & Schuell, Inc. | Methods and devices for collecting and storing clinical samples for genetic analysis |
| US6129710A (en) | 1997-05-12 | 2000-10-10 | Spectrum Biotech Inc. | Needle cannula attachment device for a disposable syringe |
| US5984940A (en) | 1997-05-29 | 1999-11-16 | Atrion Medical Products, Inc. | Lancet device |
| US5938679A (en) | 1997-10-14 | 1999-08-17 | Hewlett-Packard Company | Apparatus and method for minimally invasive blood sampling |
| US6155992A (en) | 1997-12-02 | 2000-12-05 | Abbott Laboratories | Method and apparatus for obtaining interstitial fluid for diagnostic tests |
| US5971941A (en) | 1997-12-04 | 1999-10-26 | Hewlett-Packard Company | Integrated system and method for sampling blood and analysis |
| US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
| JP2000014662A (ja) | 1998-01-22 | 2000-01-18 | Terumo Corp | 体液検査装置 |
| US6309887B1 (en) | 1998-01-27 | 2001-10-30 | Flexsite Diagnostics, Inc. | Filter paper treatment for improved diagnostic assays |
| US7056306B1 (en) | 1998-02-05 | 2006-06-06 | Mdc Investment Holdings, Inc. | Fluid sampling device with retractable needle |
| US6086545A (en) | 1998-04-28 | 2000-07-11 | Amira Medical | Methods and apparatus for suctioning and pumping body fluid from an incision |
| US5951582A (en) | 1998-05-22 | 1999-09-14 | Specialized Health Products, Inc. | Lancet apparatus and methods |
| US6503231B1 (en) | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
| US7344499B1 (en) | 1998-06-10 | 2008-03-18 | Georgia Tech Research Corporation | Microneedle device for extraction and sensing of bodily fluids |
| US6204375B1 (en) | 1998-07-31 | 2001-03-20 | Ambion, Inc. | Methods and reagents for preserving RNA in cell and tissue samples |
| DE19836559A1 (de) | 1998-08-12 | 2000-03-23 | Antigen Gmbh | Gefäß zur Entnahme von Blut |
| GB9817662D0 (en) | 1998-08-13 | 1998-10-07 | Crocker Peter J | Substance delivery |
| US20010039010A1 (en) | 1998-09-03 | 2001-11-08 | Leigh Alexander Burgoyne | Sample collection medium incorporating material for sample visualization |
| US6036659A (en) | 1998-10-09 | 2000-03-14 | Flexsite Diagnostics, Inc. | Collection device for biological samples and methods of use |
| US6746841B1 (en) | 1999-04-14 | 2004-06-08 | Whatman Inc. | FTA- coated media for use as a molecular diagnostic tool |
| DE19909602A1 (de) | 1999-03-05 | 2000-09-07 | Roche Diagnostics Gmbh | Gerät zur Entnahme von Blut für Diagnosezwecke |
| US7077828B2 (en) | 1999-03-05 | 2006-07-18 | Roche Diagnostics Gmbh | Device for withdrawing blood for diagnostic applications |
| US6132449A (en) | 1999-03-08 | 2000-10-17 | Agilent Technologies, Inc. | Extraction and transportation of blood for analysis |
| AU6048199A (en) | 1999-03-11 | 2000-09-28 | Whatman, Inc. | Solid medium and process for the storage and rapid purification of nucleic acid |
| AU4353500A (en) | 1999-04-30 | 2000-11-17 | Whatman, Inc. | Substrate including anionic detergent for purifying nucleic acid |
| AU4588000A (en) | 1999-04-30 | 2000-12-28 | Cyclops Genome Sciences Limited | Polynucleotides |
| US6818185B1 (en) * | 1999-05-28 | 2004-11-16 | Cepheid | Cartridge for conducting a chemical reaction |
| EP1187653B1 (en) | 1999-06-04 | 2010-03-31 | Georgia Tech Research Corporation | Devices for enhanced microneedle penetration of biological barriers |
| US6743211B1 (en) | 1999-11-23 | 2004-06-01 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
| US6152942A (en) | 1999-06-14 | 2000-11-28 | Bayer Corporation | Vacuum assisted lancing device |
| GB9914355D0 (en) | 1999-06-19 | 1999-08-18 | Owen Mumford Ltd | Improvements relating to blood sampling devices |
| US6531061B1 (en) * | 1999-07-21 | 2003-03-11 | Olivia M. Cholewa | Disposable dialysis cassette |
| WO2001021830A1 (en) | 1999-09-24 | 2001-03-29 | Ambion, Inc. | Nuclease inhibitor cocktail |
| WO2001043643A1 (en) | 1999-12-16 | 2001-06-21 | Alza Corporation | Device for enhancing transdermal flux of sampled agents |
| DE10006662A1 (de) | 2000-02-15 | 2001-08-23 | Antigen Produktions Gmbh | Gefäß zur Nukleinsäureanalytik |
| US6558361B1 (en) | 2000-03-09 | 2003-05-06 | Nanopass Ltd. | Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems |
| US6612111B1 (en) | 2000-03-27 | 2003-09-02 | Lifescan, Inc. | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
| WO2003026506A1 (en) | 2001-09-19 | 2003-04-03 | Terumo Kabushiki Kaisha | Apparatus for measuring component and chip |
| DE10026172A1 (de) | 2000-05-26 | 2001-11-29 | Roche Diagnostics Gmbh | System zur Entnahme von Körperflüssigkeit |
| US6506168B1 (en) | 2000-05-26 | 2003-01-14 | Abbott Laboratories | Apparatus and method for obtaining blood for diagnostic tests |
| US6540675B2 (en) | 2000-06-27 | 2003-04-01 | Rosedale Medical, Inc. | Analyte monitor |
| DE10036907B4 (de) | 2000-07-28 | 2012-03-22 | Xantec Bioanalytics Gmbh | Verfahren zur Herstellung einer Beschichtung auf einem mit Gold bedampften Glassubstrat, Beschichtung hergestellt nach diesem Verfahren und deren Verwendung |
| JP4536890B2 (ja) | 2000-09-12 | 2010-09-01 | テルモ株式会社 | 成分測定装置用チップおよび成分測定システム |
| US20080027368A1 (en) | 2000-09-27 | 2008-01-31 | Sorin Group Usa, Inc. | Disposable cartridge for a blood perfusion system |
| US20100261159A1 (en) * | 2000-10-10 | 2010-10-14 | Robert Hess | Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| US6602718B1 (en) | 2000-11-08 | 2003-08-05 | Becton, Dickinson And Company | Method and device for collecting and stabilizing a biological sample |
| US7001724B1 (en) | 2000-11-28 | 2006-02-21 | Applera Corporation | Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases |
| US7993839B2 (en) | 2001-01-19 | 2011-08-09 | General Electric Company | Methods and kits for reducing non-specific nucleic acid amplification |
| BR0206604A (pt) | 2001-01-22 | 2004-02-17 | Hoffmann La Roche | Dispositivo de lanceta que tem ação capilar |
| US6752817B2 (en) | 2001-03-26 | 2004-06-22 | Bayer Corporation | Split pressure ring for lancing device and method of operation |
| US6591124B2 (en) | 2001-05-11 | 2003-07-08 | The Procter & Gamble Company | Portable interstitial fluid monitoring system |
| US7531362B2 (en) | 2001-06-07 | 2009-05-12 | Medmira Inc. | Rapid diagnostic assay |
| WO2002100274A1 (en) | 2001-06-08 | 2002-12-19 | Hoffmann-La Roche Ag | Bodily fluid sampling device and test media cassette to be used with such a device |
| US20020188223A1 (en) | 2001-06-08 | 2002-12-12 | Edward Perez | Devices and methods for the expression of bodily fluids from an incision |
| US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
| WO2002100252A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
| CA2484062A1 (en) | 2001-08-20 | 2003-02-27 | James C. Davis | Dna purification and recovery from high particulate and solids samples |
| WO2003020924A2 (en) | 2001-09-05 | 2003-03-13 | Whatman Plc | Stable storage of proteins |
| US20040267160A9 (en) | 2001-09-26 | 2004-12-30 | Edward Perez | Method and apparatus for sampling bodily fluid |
| ES2337665T3 (es) | 2001-11-15 | 2010-04-28 | Whatman, Inc. | Procedimientos y materiales para detectar material genetico. |
| GB0129816D0 (en) | 2001-12-13 | 2002-01-30 | The Technology Partnership Plc | Testing device for chemical or biochemical analysis |
| US20030215358A1 (en) | 2002-01-15 | 2003-11-20 | Schulman Lloyd S. | Liquid permeable composition in dry reagent devices |
| US7047070B2 (en) | 2002-04-02 | 2006-05-16 | Becton, Dickinson And Company | Valved intradermal delivery device and method of intradermally delivering a substance to a patient |
| WO2003086443A1 (en) | 2002-04-11 | 2003-10-23 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for intranasal administration |
| US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
| WO2004054455A1 (en) | 2002-12-13 | 2004-07-01 | Pelikan Technologies, Inc. | Method and apparatus for measuring analytes |
| US7198606B2 (en) | 2002-04-19 | 2007-04-03 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
| US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US7258693B2 (en) | 2002-04-19 | 2007-08-21 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
| US6984485B2 (en) | 2002-04-23 | 2006-01-10 | Beckman Coulter, Inc. | Polymer-coated substrates for immobilization of biomolecules and cells |
| US7156945B2 (en) | 2002-04-24 | 2007-01-02 | Sipix Imaging, Inc. | Process for forming a patterned thin film structure for in-mold decoration |
| US6755802B2 (en) | 2002-05-06 | 2004-06-29 | Beckman Coulter, Inc. | Whole blood sampling device |
| US7303726B2 (en) | 2002-05-09 | 2007-12-04 | Lifescan, Inc. | Minimal procedure analyte test system |
| WO2003099123A1 (en) | 2002-05-22 | 2003-12-04 | Spectrx, Inc. | System and method for the extraction and monitoring of a biological fluid |
| US7482116B2 (en) | 2002-06-07 | 2009-01-27 | Dna Genotek Inc. | Compositions and methods for obtaining nucleic acids from sputum |
| WO2004005553A1 (en) | 2002-07-10 | 2004-01-15 | Massachusetts Institute Of Technology | Apparatus and method for isolating a nucleic acid from a sample |
| DE10231659B4 (de) | 2002-07-12 | 2006-01-19 | Preanalytix Gmbh | Zusammensetzung zum Binden von Nukleinsäure an eine Festphase |
| GB0217963D0 (en) | 2002-08-02 | 2002-09-11 | Cyclops Genome Sciences Ltd | Purification of nucleic acids |
| US7740600B2 (en) | 2002-08-02 | 2010-06-22 | Candela Corporation | Apparatus and method for inhibiting pain signals transmitted during a skin related medical treatment |
| US7163515B2 (en) | 2002-09-03 | 2007-01-16 | Mcnenny James H | Projectile blood collection device |
| US20040096914A1 (en) | 2002-11-20 | 2004-05-20 | Ye Fang | Substrates with stable surface chemistry for biological membrane arrays and methods for fabricating thereof |
| EP1570783A4 (en) | 2002-12-13 | 2009-09-09 | Arkray Inc | NADELEINFÜHRVORRICHTUNG |
| EP1581114B1 (en) | 2002-12-30 | 2014-04-30 | Roche Diagnostics GmbH | Flexible test strip lancet device |
| EP1589873B1 (en) | 2003-01-29 | 2011-12-21 | Roche Diagnostics GmbH | Integrated lancing test strip |
| US7267950B2 (en) | 2003-05-01 | 2007-09-11 | Veridex, Lcc | Rapid extraction of RNA from cells and tissues |
| JP4241183B2 (ja) | 2003-05-19 | 2009-03-18 | 株式会社日立ハイテクノロジーズ | 核酸回収方法及び核酸回収キット |
| JP2007502428A (ja) | 2003-05-23 | 2007-02-08 | ユィロス・パテント・アクチボラグ | 非湿潤性表面に基づく流体機能 |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| US7250270B2 (en) | 2003-06-13 | 2007-07-31 | Ambion, Inc. | Methods and compositions for preparing tissue samples for RNA extraction |
| ATE514791T1 (de) | 2003-07-09 | 2011-07-15 | Genvault Corp | Raumtemperatur-eluierung der nukleinsäuren |
| CN101554601A (zh) | 2003-08-05 | 2009-10-14 | 贝克顿·迪金森公司 | 收集生物流体样品及处理选定成分的装置和方法 |
| MXPA06001373A (es) | 2003-08-12 | 2006-05-15 | Becton Dickinson Co | Dispositivo de infusion similar a un parche. |
| CA2538038C (en) | 2003-09-11 | 2015-10-27 | Theranos, Inc. | Medical device for analyte monitoring and drug delivery |
| JP3714940B2 (ja) | 2003-11-07 | 2005-11-09 | 株式会社日立ハイテクノロジーズ | Ｒｎａ抽出方法、および生体材料の分析方法 |
| US20110059441A1 (en) | 2007-04-16 | 2011-03-10 | Mcmaster University | Methof of producing bioactive paper |
| US7521021B2 (en) | 2003-11-26 | 2009-04-21 | Leica Biosvstems St. Louis Llc | System for in situ processing of a tissue specimen |
| CN1902492A (zh) | 2003-12-30 | 2007-01-24 | 3M创新有限公司 | 基底及结合到该基底上的化合物 |
| US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
| US7354515B2 (en) | 2004-02-23 | 2008-04-08 | Millennium Medical Technologies, Inc. | Fluid concentrator |
| US20050222539A1 (en) | 2004-03-30 | 2005-10-06 | Pediamed Pharmaceuticals, Inc. | Automatic injection device |
| WO2005094920A1 (en) | 2004-03-30 | 2005-10-13 | Novo Nordisk A/S | Actuator system comprising lever mechanism |
| US7045295B2 (en) | 2004-04-02 | 2006-05-16 | Hematologics, Inc. | Method for collecting purified cells |
| US20080176209A1 (en) | 2004-04-08 | 2008-07-24 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
| CA2560513A1 (en) | 2004-04-08 | 2005-12-01 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
| US20060099567A1 (en) | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
| CN1980738A (zh) | 2004-04-09 | 2007-06-13 | 科研智囊团有限公司 | 用于收集、储存和运输生物样本的设备和方法 |
| DE102004021780B4 (de) | 2004-04-30 | 2008-10-02 | Siemens Ag | Verfahren und Anordnung zur DNA-Isolierung mit Trockenreagenzien |
| EP1746419A1 (en) | 2004-04-30 | 2007-01-24 | Arkray, Inc. | Sample analyzing tool |
| US9101302B2 (en) | 2004-05-03 | 2015-08-11 | Abbott Diabetes Care Inc. | Analyte test device |
| US8142723B2 (en) | 2004-05-03 | 2012-03-27 | Chromologic, LLC | Tag free bio sensing micro strip |
| CN1968651A (zh) | 2004-05-07 | 2007-05-23 | 贝克顿·迪金森公司 | 凸轮致动的医疗穿刺装置及方法 |
| WO2005116651A2 (en) | 2004-05-24 | 2005-12-08 | Diasys Corporation | Method and device for testing for bence-jones protein |
| EP1758937B1 (en) | 2004-05-24 | 2009-09-02 | Genvault Corporation | Stable protein storage and stable nucleic acid storage in recoverable form |
| EP1765195B1 (en) | 2004-06-25 | 2014-07-30 | Facet Technologies, LLC | Low cost safety lancet |
| US7776530B2 (en) | 2004-06-29 | 2010-08-17 | Wallac Oy | Integrated nucleic acid analysis |
| US20060030790A1 (en) | 2004-08-06 | 2006-02-09 | Braig James R | Sample element with barrier material and vacuum |
| US20060068399A1 (en) * | 2004-09-24 | 2006-03-30 | Cepheid | Multiple bead reagent system for protein based assays with optimized matrices |
| WO2006047787A2 (en) | 2004-10-27 | 2006-05-04 | Exact Sciences Corporation | Method for monitoring disease progression or recurrence |
| ATE464381T1 (de) | 2004-12-23 | 2010-04-15 | Ge Healthcare Bio Sciences | Rna-amplifikation auf ligationsbasis |
| US20090208919A1 (en) | 2005-01-21 | 2009-08-20 | Argylla Technologies, Llp | Particle matrix for storage of biomolecules |
| US20060240451A1 (en) | 2005-02-09 | 2006-10-26 | Epicentre Technologies | Compositions and methods employing 5' phosphate-dependent nucleic acid exonucleases |
| US7695442B2 (en) | 2005-04-12 | 2010-04-13 | Roche Diagnostics Operations, Inc. | Integrated lancing test strip with retractable lancet |
| CN101175853A (zh) | 2005-03-16 | 2008-05-07 | Dna吉诺特克股份有限公司 | 用于保存来自体液的核酸的组合物和方法 |
| GB0505909D0 (en) | 2005-03-23 | 2005-04-27 | Univ Leeds | Formulations |
| US20060234251A1 (en) * | 2005-04-19 | 2006-10-19 | Lumigen, Inc. | Methods of enhancing isolation of RNA from biological samples |
| US7858384B2 (en) | 2005-04-29 | 2010-12-28 | Kimberly-Clark Worldwide, Inc. | Flow control technique for assay devices |
| US7803319B2 (en) | 2005-04-29 | 2010-09-28 | Kimberly-Clark Worldwide, Inc. | Metering technique for lateral flow assay devices |
| KR100716015B1 (ko) | 2005-06-08 | 2007-05-08 | 유재천 | 란셋 장치 및 이를 이용한 혈액의 채취 및 주입 방법 |
| US20070015165A1 (en) | 2005-07-13 | 2007-01-18 | Sigma-Aldrich Co. | Method for the isolation of RNA from biological sources |
| USD548339S1 (en) | 2005-08-09 | 2007-08-07 | Recuperatio Limited | Skin treatment device |
| CA2620943A1 (en) | 2005-09-02 | 2007-03-08 | Iomai Corporation | Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs and uses thereof |
| EP1931800A4 (en) | 2005-09-15 | 2011-06-15 | Artemis Health Inc | SYSTEMS AND METHOD FOR ENRICHING ANALYTES |
| USD546440S1 (en) | 2005-09-27 | 2007-07-10 | C.R. Bard, Inc. | Injectable power port |
| US8057404B2 (en) | 2005-10-12 | 2011-11-15 | Panasonic Corporation | Blood sensor, blood testing apparatus, and method for controlling blood testing apparatus |
| US7816122B2 (en) | 2005-10-18 | 2010-10-19 | Idexx Laboratories, Inc. | Lateral flow device with onboard reagents |
| JP4699868B2 (ja) | 2005-11-04 | 2011-06-15 | 株式会社日立ハイテクノロジーズ | 核酸精製方法及び核酸精製器具 |
| CA2625638C (en) | 2005-11-08 | 2014-03-11 | Surmodics, Inc. | Ultra-thin photo-polymer coatings and uses thereof |
| US8030034B2 (en) | 2005-12-09 | 2011-10-04 | Promega Corporation | Nucleic acid purification with a binding matrix |
| US8333712B2 (en) | 2006-01-11 | 2012-12-18 | Canon Kabushiki Kaisha | Body fluid sampling device |
| EP1983889A4 (en) | 2006-01-31 | 2009-09-16 | Univ Chicago | METHOD AND DEVICE FOR ANALYZING BLOOD COAGULATION |
| WO2007100986A2 (en) * | 2006-02-24 | 2007-09-07 | Rosetta Inpharmatics Llc | Extraction and diagnostic fluid devices, systems and methods of use |
| WO2007108515A1 (ja) | 2006-03-22 | 2007-09-27 | Matsushita Electric Industrial Co., Ltd. | 血液検査装置 |
| US8741230B2 (en) | 2006-03-24 | 2014-06-03 | Theranos, Inc. | Systems and methods of sample processing and fluid control in a fluidic system |
| EP1852069B1 (de) | 2006-05-04 | 2015-06-17 | Roche Diagnostics GmbH | Blutentnahmesystem zur Entnahme von Blut aus einem Körperteil für Diagnosezwecke |
| GB0610553D0 (en) | 2006-05-26 | 2006-07-05 | Bakhtyari Nejad Esfahani Arash | Dressing |
| EP3260556B1 (en) | 2006-05-31 | 2019-07-31 | Sequenom, Inc. | Methods for the extraction of nucleic acid from a sample |
| US8163535B2 (en) | 2006-06-26 | 2012-04-24 | Blood Cell Storage, Inc. | Devices and processes for nucleic acid extraction |
| JP2008022988A (ja) | 2006-07-19 | 2008-02-07 | Ritsumeikan | 採血装置 |
| ATE540663T1 (de) | 2006-08-18 | 2012-01-15 | Medingo Ltd | Verfahren und vorrichtungen zur abgabe einer flüssigkeit an ein reservoir einer flüssigkeitsabgabevorrichtung |
| US7736338B2 (en) | 2006-08-23 | 2010-06-15 | Medtronic Minimed, Inc. | Infusion medium delivery system, device and method with needle inserter and needle inserter device and method |
| US8080645B2 (en) | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US20100099149A1 (en) | 2006-10-06 | 2010-04-22 | Dna Genotek Inc. | Stabilizing compositions and methods for extraction of ribonucleic acid |
| DE102006047519A1 (de) | 2006-10-07 | 2008-05-21 | Fresenius Kabi Deutschland Gmbh | Port für einen Katheter |
| US9163229B2 (en) | 2006-10-10 | 2015-10-20 | Trovagene, Inc. | Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media |
| JP2008099991A (ja) | 2006-10-20 | 2008-05-01 | Olympus Corp | 採血装置 |
| JP2008099992A (ja) | 2006-10-20 | 2008-05-01 | Olympus Corp | 採血装置 |
| JP2008099988A (ja) | 2006-10-20 | 2008-05-01 | Olympus Corp | 採血装置 |
| US7521213B2 (en) | 2006-12-01 | 2009-04-21 | Quest Diagnostics Investments Incorporated | Sample processing for nucleic acid amplification |
| US8377379B2 (en) | 2006-12-15 | 2013-02-19 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay device |
| GB0700374D0 (en) | 2007-01-09 | 2007-02-14 | Oncomethylome Sciences S A | NDRG family methylation markers |
| EP2118260A2 (en) | 2007-01-16 | 2009-11-18 | Genvault Corporation | Nanoparticles useful for biomolecule storage |
| US7748283B2 (en) | 2007-02-16 | 2010-07-06 | Whatman, Inc. | Controlled transfer biological sample collection devices and methods of using such devices |
| US8469986B2 (en) | 2007-03-30 | 2013-06-25 | Stat Medical Devices, Inc. | Lancet device with combined trigger and cocking mechanism and method |
| EP2545854B1 (en) | 2007-04-30 | 2014-06-04 | Roche Diagnostics GmbH | Instrument and system for producing a sample of a body liquid and for analysis thereof |
| EP2164799B1 (en) | 2007-05-16 | 2018-12-26 | Mystic Pharmaceuticals, Inc. | Combination unit dose dispensing containers |
| CA2922219C (en) | 2007-05-17 | 2018-11-13 | Advance Dx, Inc. | Fluid separator collection card |
| CA2754884C (en) | 2007-06-21 | 2013-04-30 | Gen-Probe Incorporated | Methods of concentrating an analyte |
| MX2010000703A (es) | 2007-07-19 | 2010-07-29 | Medical Components Inc | Ensamble de puerto de acceso venoso con indicaciones que se distinguen para rayos x. |
| US20090053704A1 (en) | 2007-08-24 | 2009-02-26 | Natalia Novoradovskaya | Stabilization of nucleic acids on solid supports |
| EP2195050B1 (en) | 2007-08-29 | 2011-05-04 | Brighter AB | A portable medical apparatus comprising sampling means, determining means and injecting means |
| JP2009092651A (ja) | 2007-09-20 | 2009-04-30 | Fujifilm Corp | 担体およびその製造方法 |
| FR2923151B1 (fr) | 2007-11-02 | 2010-09-03 | Commissariat Energie Atomique | Dispositif de prelevement sanguin comportant au moins un filtre . |
| US20090155838A1 (en) * | 2007-11-28 | 2009-06-18 | Smart Tube, Inc. | Devices, systems and methods for the collection, stimulation, stabilization, and analysis of a biological sample |
| US20090143570A1 (en) | 2007-11-30 | 2009-06-04 | Ge Healthcare Bio-Sciences Corp. | Method for isolation of genomic dna, rna and proteins from a single sample |
| WO2009081405A2 (en) | 2007-12-25 | 2009-07-02 | Rapidx Ltd. | Devices and methods for reduced-pain blood sampling |
| WO2009090174A1 (en) | 2008-01-17 | 2009-07-23 | Whatman Inc | Composite membrane blends comprising ionic branch polymers and methods of use |
| US7766846B2 (en) | 2008-01-28 | 2010-08-03 | Roche Diagnostics Operations, Inc. | Rapid blood expression and sampling |
| CA2713545A1 (en) | 2008-01-30 | 2009-08-06 | Novartis Ag | Two stage enrichment of cell-free fetal dna in maternal plasma |
| PL2252349T3 (pl) | 2008-02-13 | 2012-01-31 | Unomedical As | Uszczelnienie między częścią kaniulową a drogą przepływu płynu |
| AU2009219375B2 (en) | 2008-02-29 | 2014-10-02 | Medical Components, Inc. | Venous access port assembly with push surfaces |
| EP2128169A1 (de) | 2008-05-30 | 2009-12-02 | Qiagen GmbH | Verfahren zur Isolierung von kurzkettigen Nukleinsäuren |
| WO2009145920A1 (en) | 2008-05-30 | 2009-12-03 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
| JP5642066B2 (ja) | 2008-06-06 | 2014-12-17 | インテュイティ メディカル インコーポレイテッド | 体液の試料内に含まれている検体の存在または濃度を決定する検定を行う方法および装置 |
| US20100209957A1 (en) | 2008-06-20 | 2010-08-19 | Genvault Corporation | Biosample storage devices and methods of use thereof |
| US20100099074A1 (en) | 2008-07-25 | 2010-04-22 | Garry Nolan | Collection device and method for stimulating and stabilizing a biological sample |
| EP3206009B1 (en) | 2008-08-21 | 2025-05-14 | DNA Genotek Inc. | Sample receiving device |
| EP2334792B1 (en) | 2008-09-12 | 2020-09-09 | GenTegra LLC | Matrices and media for storage and stabilization of biomolecules |
| GB0818609D0 (en) | 2008-10-10 | 2008-11-19 | Univ Hull | apparatus and method |
| US8932271B2 (en) | 2008-11-13 | 2015-01-13 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
| US8961787B2 (en) | 2008-12-01 | 2015-02-24 | General Electric Company | Systems and methods for processing complex biological materials |
| EP2376689B1 (en) | 2008-12-23 | 2023-09-13 | 3M Innovative Properties Co. | Functionalized nonwoven article |
| US8337464B2 (en) | 2009-01-29 | 2012-12-25 | Vital Access Corporation | Vascular access ports and related methods |
| US8807169B2 (en) | 2009-02-12 | 2014-08-19 | Picolife Technologies, Llc | Flow control system for a micropump |
| CA2751470C (en) | 2009-02-16 | 2016-07-26 | Epicentre Technologies Corporation | Template-independent ligation of single-stranded dna |
| DE202010018569U1 (de) | 2009-02-18 | 2017-09-26 | Streck Inc. | Konservierung zellfreier Nukleinsäuren |
| US20120149128A1 (en) | 2009-02-23 | 2012-06-14 | Victor Manneh | Assays and assay devices |
| US20110105951A1 (en) | 2009-10-30 | 2011-05-05 | Seventh Sense Biosystems, Inc. | Systems and methods for treating, sanitizing, and/or shielding the skin or devices applied to the skin |
| US9041541B2 (en) | 2010-01-28 | 2015-05-26 | Seventh Sense Biosystems, Inc. | Monitoring or feedback systems and methods |
| WO2012018486A2 (en) | 2010-07-26 | 2012-02-09 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
| US9295417B2 (en) | 2011-04-29 | 2016-03-29 | Seventh Sense Biosystems, Inc. | Systems and methods for collecting fluid from a subject |
| US20110105952A1 (en) | 2009-10-30 | 2011-05-05 | Seventh Sense Biosystems, Inc. | Relatively small devices applied to the skin, modular systems, and methods of use thereof |
| WO2010101625A2 (en) | 2009-03-02 | 2010-09-10 | Seventh Sense Biosystems, Inc. | Oxygen sensor |
| CN102405018B (zh) | 2009-03-02 | 2014-11-19 | 第七感生物系统有限公司 | 与血液取样相关联的技术和装置 |
| US20110105872A1 (en) | 2009-10-30 | 2011-05-05 | Seventh Sense Biosystems, Inc. | Systems and methods for application to skin and control of actuation, delivery, and/or perception thereof |
| EP2241252A1 (de) | 2009-03-17 | 2010-10-20 | F. Hoffmann-La Roche AG | Testvorrichtung insbesondere für Blutzuckertests |
| US20120100538A1 (en) | 2009-03-24 | 2012-04-26 | Biocept, Inc. | Devices and methods of cell capture and analysis |
| US9415392B2 (en) | 2009-03-24 | 2016-08-16 | The University Of Chicago | Slip chip device and methods |
| JP2012523888A (ja) | 2009-04-15 | 2012-10-11 | シー・アール・バード・インコーポレーテッド | 統合された流体管理システムを有する生検機器 |
| WO2010132453A2 (en) | 2009-05-11 | 2010-11-18 | Nexus Dx, Inc. | Methods and compositions for analyte detection |
| EP2430195B1 (en) | 2009-05-11 | 2019-01-23 | Biomatrica, INC. | Compositions and methods for biological sample storage |
| WO2010144682A1 (en) | 2009-06-12 | 2010-12-16 | Micronics, Inc. | Rehydratable matrices for dry storage of taq polymerase in a microfluidic device |
| CN102497814B (zh) | 2009-07-30 | 2015-01-28 | 贝克顿·迪金森公司 | 具有鞍状尖端的采血设备 |
| WO2011014741A1 (en) | 2009-07-31 | 2011-02-03 | Artemis Health, Inc. | Methods and compositions for cell stabilization |
| US20110040208A1 (en) | 2009-08-11 | 2011-02-17 | Abbott Diabetes Care Inc. | Integrated lancet and test strip and methods of making and using same |
| US8222397B2 (en) | 2009-08-28 | 2012-07-17 | Promega Corporation | Methods of optimal purification of nucleic acids and kit for use in performing such methods |
| US20130018279A1 (en) | 2009-09-01 | 2013-01-17 | Pathway Genomics | "blood sample collection apparatus and kits" |
| US20120165697A1 (en) | 2009-09-04 | 2012-06-28 | Atomo Diagnostics Pty Ltd | Sample collecting device |
| JP5784031B2 (ja) | 2009-10-30 | 2015-09-24 | セブンス センス バイオシステムズ，インコーポレーテッド | 皮膚に適用される比較的小型のデバイス、モジュラーシステム、およびその使用方法 |
| CN102612343B (zh) | 2009-11-17 | 2015-11-25 | C·R·巴德股份有限公司 | 包括锚定装置和标识部分的包覆模制的进入端口 |
| WO2011065972A2 (en) | 2009-11-24 | 2011-06-03 | Seventh Sense Biosystems, Inc. | Patient-enacted sampling technique |
| EP2519631B1 (en) | 2009-12-29 | 2017-02-15 | GE Healthcare Bio-Sciences Corp. | Improvements to nucleic acid elution |
| JP5826766B2 (ja) | 2010-01-13 | 2015-12-02 | セブンス センス バイオシステムズ，インコーポレーテッド | 試料採取デバイスインタフェース |
| EP3243435A1 (en) | 2010-01-13 | 2017-11-15 | Seventh Sense Biosystems, Inc. | Sampling device interfaces |
| CN102811754B (zh) | 2010-01-13 | 2017-05-17 | 第七感生物系统有限公司 | 流体的快速输送和/或抽出 |
| US8657763B2 (en) | 2010-01-19 | 2014-02-25 | Christopher A. Jacobs | Vacuum assisted lancing system with elective vacuum release and method for blood extraction with minimal pain |
| US8426151B2 (en) | 2010-02-10 | 2013-04-23 | Companion Diagnostics Inc. | Systems and methods for the detection of biomarkers |
| US20110224106A1 (en) | 2010-03-10 | 2011-09-15 | Ibis Biosciences, Inc. | Production Of Single-Stranded Circular Nucleic Acid |
| US20110306853A1 (en) | 2010-03-19 | 2011-12-15 | Michael Darryl Black | Body fluid sampling/fluid delivery device |
| EP2555918A1 (en) | 2010-04-06 | 2013-02-13 | Genvault Corporation | Stabilized chemical dehydration of biological material |
| US20130102501A1 (en) | 2010-04-14 | 2013-04-25 | Cornell University | Device for recovery and isolation of biomolecules |
| AU2011244348B2 (en) | 2010-04-20 | 2015-02-12 | Octapharma Ag | New stabilizing agent for pharmaceutical proteins |
| EP2388312A1 (en) | 2010-05-17 | 2011-11-23 | Curetis AG | Universally applicable lysis buffer and processing methods for the lysis of bodily samples |
| US20120158100A1 (en) | 2010-06-21 | 2012-06-21 | Kevin Schomacker | Driving Microneedle Arrays into Skin and Delivering RF Energy |
| JP5514008B2 (ja) | 2010-06-22 | 2014-06-04 | ニプロ株式会社 | ディスポーザブル型穿刺器具 |
| WO2011163347A2 (en) | 2010-06-23 | 2011-12-29 | Seventh Sense Biosystems, Inc. | Sampling devices and methods involving relatively little pain |
| WO2012009613A1 (en) | 2010-07-16 | 2012-01-19 | Seventh Sense Biosystems, Inc. | Low-pressure environment for fluid transfer devices |
| US9845489B2 (en) | 2010-07-26 | 2017-12-19 | Biomatrica, Inc. | Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
| CA2806670A1 (en) | 2010-07-26 | 2012-02-09 | Biomatrica, Inc. | Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
| WO2012015926A2 (en) | 2010-07-27 | 2012-02-02 | Northwestern University | Devices and methods for filtering blood plasma |
| WO2012021801A2 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
| EP2954916A3 (en) | 2010-08-13 | 2016-04-20 | Seventh Sense Biosystems, Inc. | Clinical and/or consumer techniques and devices |
| AU2011293832B2 (en) | 2010-08-26 | 2014-07-17 | Spot Bioscience, Llc | Biological fluid sampling and storage apparatus for remote use |
| PL2627255T3 (pl) | 2010-10-15 | 2016-10-31 | Zespół do pobierania próbek | |
| US8474332B2 (en) | 2010-10-20 | 2013-07-02 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
| EP2992827B1 (en) | 2010-11-09 | 2017-04-19 | Seventh Sense Biosystems, Inc. | Systems and interfaces for blood sampling |
| CN103370412B (zh) | 2010-12-04 | 2015-07-22 | 万芬 | 核糖核酸稳定性增强剂 |
| US20120152743A1 (en) | 2010-12-17 | 2012-06-21 | General Electric Company | Method for electroeluting genetic material from dried samples |
| WO2012092260A1 (en) | 2010-12-27 | 2012-07-05 | Ibis Biosciences, Inc. | Compositions and methods for producing single-stranded circular dna |
| US8852123B2 (en) | 2010-12-30 | 2014-10-07 | Roche Diagnostics Operations, Inc. | Handheld medical diagnostic devices housing with sample transfer |
| EP2673031B1 (en) | 2011-02-09 | 2020-07-15 | Becton, Dickinson and Company | Medical infusion device comprising a self-contained torsion spring inserter |
| SG192270A1 (en) * | 2011-02-17 | 2013-08-30 | Nestec Sa | Apparatus and method for isolating leukocytes and tumor cells by filtration |
| GB201103258D0 (en) | 2011-02-25 | 2011-04-13 | Ge Healthcare Uk Ltd | Solid support and method of enhancing the recovery of biological material therefrom |
| GB201103256D0 (en) | 2011-02-25 | 2011-04-13 | Ge Healthcare Uk Ltd | Solid support and method of recovering biological material therefrom |
| GB201103257D0 (en) | 2011-02-25 | 2011-04-13 | Ge Healthcare Uk Ltd | Paper support and method of recovering biological material therefrom |
| AU2012236109A1 (en) | 2011-04-01 | 2013-11-21 | Occam Biolabs, Inc. | Methods and kits for detecting cell-free pathogen-specific nucleic acids |
| US20120271125A1 (en) | 2011-04-11 | 2012-10-25 | Seventh Sense Biosystems, Inc. | Devices and methods for delivery and/or withdrawal of fluids and preservation of withdrawn fluids |
| KR20140034200A (ko) | 2011-04-29 | 2014-03-19 | 세븐쓰 센스 바이오시스템즈, 인크. | 혈액 스폿들 또는 다른 신체 유체들을 수집 및/또는 조작하기 위한 시스템들 및 방법들 |
| US20130158468A1 (en) | 2011-12-19 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving material with respect to a subject surface |
| CN103874460B (zh) | 2011-04-29 | 2016-06-22 | 第七感生物系统有限公司 | 一种用于从受验者的皮肤接收血液或其它物质的装置 |
| JP5559096B2 (ja) | 2011-05-10 | 2014-07-23 | 株式会社堀場製作所 | 血球計数用試薬、及び血液検査方法 |
| CA2843945C (en) | 2011-08-03 | 2022-06-21 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
| CN103827303B (zh) | 2011-09-26 | 2021-10-22 | 普瑞阿那利提克斯有限公司 | 细胞外核酸的稳定化和分离 |
| GB2496122A (en) | 2011-10-31 | 2013-05-08 | Ge Healthcare Bio Sciences Ab | Biological sample preservation on paper |
| US9554736B2 (en) | 2011-11-29 | 2017-01-31 | Teleflex Medical Incorporated | Device with integrated allergy testing |
| WO2013082273A1 (en) * | 2011-11-30 | 2013-06-06 | Wellstat Diagnostics, Llc. | Filtration module |
| US20130150811A1 (en) | 2011-12-12 | 2013-06-13 | Angiodynamics, Inc. | High-Flow Port Stem |
| CN103173432B (zh) | 2011-12-22 | 2020-08-04 | 通用电气公司 | 分离核酸的方法及装置 |
| US20130211289A1 (en) | 2012-01-25 | 2013-08-15 | Tasso, Inc. | Handheld Device for Drawing, Collecting, and Analyzing Bodily Fluid |
| PT2814981T (pt) | 2012-02-13 | 2017-10-03 | Streck Inc | Dispositivo de colheita de sangue para estabilizar adn plasmático livre de célula |
| US9353393B2 (en) | 2012-02-15 | 2016-05-31 | General Electric Company | Methods and kits for reducing non-specific nucleic acid amplification |
| JP6008940B2 (ja) | 2012-03-13 | 2016-10-19 | シチズンホールディングス株式会社 | 半導体発光装置及びその製造方法 |
| US9933343B2 (en) | 2012-03-14 | 2018-04-03 | Chromologic Llc | Integrated membrane for preservation of biomolecules |
| US9795960B2 (en) | 2012-03-31 | 2017-10-24 | Dbs System Sa | Device and method for dried fluid spot analysis |
| EP2839260B1 (en) | 2012-04-20 | 2018-07-18 | Talis Biomedical Corporation | Fluidic devices and systems for sample preparation or autonomous analysis |
| US9808798B2 (en) | 2012-04-20 | 2017-11-07 | California Institute Of Technology | Fluidic devices for biospecimen preservation |
| US10076630B2 (en) | 2012-04-24 | 2018-09-18 | The Queen Elizabeth Hospital King's Lynn Nhs Foundation Trust | Device for performing regional anesthesia |
| US9044738B2 (en) | 2012-04-30 | 2015-06-02 | General Electric Company | Methods and compositions for extraction and storage of nucleic acids |
| US9040675B2 (en) | 2012-04-30 | 2015-05-26 | General Electric Company | Formulations for nucleic acid stabilization on solid substrates |
| US9480966B2 (en) * | 2012-04-30 | 2016-11-01 | General Electric Company | Substrates and methods for collection, stabilization and elution of biomolecules |
| US9040679B2 (en) | 2012-04-30 | 2015-05-26 | General Electric Company | Methods and compositions for extraction and storage of nucleic acids |
| ES2385079B1 (es) | 2012-05-08 | 2013-05-24 | Leventon S.A.U. | Reductor de presión para el suministro de medicamentos a un paciente y procedimiento de fabricación correspondiente |
| US9081001B2 (en) | 2012-05-15 | 2015-07-14 | Wellstat Diagnostics, Llc | Diagnostic systems and instruments |
| US9213043B2 (en) | 2012-05-15 | 2015-12-15 | Wellstat Diagnostics, Llc | Clinical diagnostic system including instrument and cartridge |
| US8777170B2 (en) | 2012-06-05 | 2014-07-15 | Lenmark Holdings, Llc | Display article support systems |
| WO2014018558A1 (en) | 2012-07-23 | 2014-01-30 | Tasso, Inc. | Methods, systems, and devices relating to open microfluidic channels |
| US9399986B2 (en) | 2012-07-31 | 2016-07-26 | General Electric Company | Devices and systems for isolating biomolecules and associated methods thereof |
| US20150259671A1 (en) | 2012-07-31 | 2015-09-17 | General Electric Company | Devices and systems for isolating biomolecules and associated methods thereof |
| US20140038172A1 (en) | 2012-08-06 | 2014-02-06 | Vivebio, Llc | Matrix and System for Preserving Biological Specimens for Qualitative and Quantitative Analysis |
| US9427184B2 (en) | 2012-09-06 | 2016-08-30 | Theranos, Inc. | Systems, devices, and methods for bodily fluid sample collection |
| US9636062B2 (en) | 2012-09-06 | 2017-05-02 | Theranos, Inc. | Systems, devices, and methods for bodily fluid sample collection |
| DE102012019400A1 (de) | 2012-10-04 | 2014-04-10 | Gerresheimer Regensburg Gmbh | Stechhilfevorrichtung zur Blutprobenentnahme |
| US20140358036A1 (en) | 2012-12-05 | 2014-12-04 | Theranos, Inc. | Bodily Fluid Sample Collection and Transport |
| AU2013356680A1 (en) | 2012-12-05 | 2015-05-28 | Theranos Ip Company, Llc | Systems, devices, and methods for bodily fluid sample collection and transport |
| US20140342371A1 (en) | 2012-12-05 | 2014-11-20 | Theranos, Inc. | Bodily Fluid Sample Collection and Transport |
| ES2692726T3 (es) | 2012-12-20 | 2018-12-04 | General Electric Company | Formulaciones para la estabilización de ácidos nucleicos en sustratos sólidos |
| EP2948121B1 (en) | 2013-01-23 | 2017-11-29 | C.R. Bard Inc. | Low-profile access port |
| US11420033B2 (en) | 2013-01-23 | 2022-08-23 | C. R. Bard, Inc. | Low-profile single and dual vascular access device |
| US9623409B2 (en) | 2013-03-11 | 2017-04-18 | Cue Inc. | Cartridges, kits, and methods for enhanced mixing for detection and quantification of analytes |
| US20140272925A1 (en) | 2013-03-14 | 2014-09-18 | Chromologic Llc | Plasma Separation Apparatus, Method and System |
| WO2014153181A1 (en) | 2013-03-14 | 2014-09-25 | Spot On Sciences, Inc. | Biological sample collection and preservation |
| US20140323911A1 (en) | 2013-03-15 | 2014-10-30 | Theranos, Inc. | Methods and devices for sample collection and sample separation |
| US20150273467A1 (en) | 2013-03-15 | 2015-10-01 | Theranos, Inc. | Methods and devices for sample collection and sample separation |
| US9795929B2 (en) | 2013-03-15 | 2017-10-24 | Theranos, Inc. | Systems, devices, and methods for bodily fluid separation materials |
| US10238812B2 (en) | 2013-03-15 | 2019-03-26 | Edge Systems Llc | Skin treatment systems and methods using needles |
| US9380973B2 (en) | 2013-04-15 | 2016-07-05 | Becton, Dickinson And Company | Biological fluid sampling transfer device and biological fluid separation and testing system |
| EP3135377A1 (en) | 2013-04-15 | 2017-03-01 | Becton, Dickinson and Company | Biological fluid collection device and biological fluid separation and testing system |
| BR112015026252B1 (pt) | 2013-04-15 | 2022-03-22 | Becton, Dickinson And Company | Dispositivo de coleta de fluido biológico e sistema de coleta e teste de fluido biológico |
| WO2014172233A1 (en) | 2013-04-15 | 2014-10-23 | Becton, Dickinson And Company | Biological fluid transfer device and biological fluid sampling system |
| US9408568B2 (en) | 2013-04-15 | 2016-08-09 | Becton, Dickinson And Company | Biological fluid sampling device |
| EP2986383B1 (en) | 2013-04-15 | 2020-08-26 | Becton, Dickinson and Company | Biological fluid separation device and biological fluid separation and testing system |
| MX369605B (es) | 2013-04-15 | 2019-11-13 | Becton Dickinson Co | Dispositivo de transferencia de muestreo de fluidos biologicos y sistema de separacion y analisis de fluidos biologicos. |
| WO2014172247A1 (en) | 2013-04-15 | 2014-10-23 | Becton, Dickinson And Company | Blood sampling transfer device |
| CN105491883B (zh) | 2013-06-13 | 2018-11-02 | 生物马特里卡公司 | 细胞稳定化 |
| JP6523263B2 (ja) | 2013-06-13 | 2019-05-29 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 分析デバイス |
| ES2676697T3 (es) | 2013-07-16 | 2018-07-24 | Rene La Fontaine | Módulo de aguja e instrumento para perforar la piel |
| US9938568B2 (en) | 2013-07-26 | 2018-04-10 | General Electric Company | Ligase-assisted nucleic acid circularization and amplification |
| US10655167B2 (en) | 2013-07-26 | 2020-05-19 | General Electric Company | Ligase-assisted nucleic acid circularization and amplification |
| US9217167B2 (en) | 2013-07-26 | 2015-12-22 | General Electric Company | Ligase-assisted nucleic acid circularization and amplification |
| US9644232B2 (en) | 2013-07-26 | 2017-05-09 | General Electric Company | Method and device for collection and amplification of circulating nucleic acids |
| WO2015022410A1 (en) | 2013-08-16 | 2015-02-19 | General Electric Company | Methods and compositions for extraction and storage of nucleic acids |
| CA2922806A1 (en) * | 2013-08-28 | 2015-03-05 | Cytonics Corporation | Systems, compositions, and methods for transplantation and treating conditions utilizing a composition comprising a wild-type or a variant a2m polypeptide or portion thereof |
| WO2015061743A1 (en) | 2013-10-24 | 2015-04-30 | Theranos, Inc. | Systems and methods for ordering laboratory tests and providing results thereof |
| US9719082B2 (en) | 2013-10-31 | 2017-08-01 | General Electric Company | Substrates and associated methods for elution of nucleic acids |
| US9534214B2 (en) | 2013-10-31 | 2017-01-03 | General Electric Company | Substrates and associated methods for elution of nucleic acids |
| CN113477149B (zh) | 2013-11-06 | 2023-09-12 | 贝克顿·迪金森公司 | 微流体性装置和制造和使用其的方法 |
| US20150164398A1 (en) | 2013-11-11 | 2015-06-18 | Theranos, Inc. | Methods and systems for a sample collection device with a novelty exterior |
| US20150166956A1 (en) | 2013-12-16 | 2015-06-18 | General Electric Company | Devices for separation of particulates, associated methods and systems |
| EP3083056B1 (en) | 2013-12-20 | 2023-04-05 | Spot Bioscience, LLC | Whole blood separation sampling apparatus |
| EP3082901B1 (en) | 2013-12-20 | 2019-05-15 | Sanofi-Aventis Deutschland GmbH | Drug delivery device with disposable cartridge and disposable injector |
| GB201401133D0 (en) | 2014-01-23 | 2014-03-12 | Renephra Ltd | Fluid extraction device, applicator device and associated methods |
| US20150211967A1 (en) | 2014-01-29 | 2015-07-30 | Trajan Scientific Australia Pty Ltd | Preparation of samples for analysis and sampling device therefor |
| HK1232291A1 (zh) * | 2014-04-25 | 2018-01-05 | Global Life Sciences Solutions Operations UK Ltd | 用於生物分子的收集、稳定和洗脱的基材和方法 |
| JP6669672B2 (ja) | 2014-06-10 | 2020-03-18 | バイオマトリカ，インク． | 周囲温度における血液サンプル中の変性されていないポリペプチド、核酸、およびエキソソームの安定化 |
| ES2864412T3 (es) | 2014-07-18 | 2021-10-13 | Becton Dickinson Co | Dispositivo de lanceta con retirada de la primera gota |
| US9901922B2 (en) | 2014-07-25 | 2018-02-27 | General Electric Company | Sample collection and transfer device |
| US9480981B2 (en) | 2014-07-25 | 2016-11-01 | General Electric Company | Sample collection and transfer device |
| CN113440134A (zh) | 2014-08-01 | 2021-09-28 | 塔索公司 | 用于重力增强的微流体采集、液体的处理和输送的装置、系统和方法 |
| US10779757B2 (en) | 2014-08-01 | 2020-09-22 | Tasso, Inc. | Devices, systems and methods for gravity-enhanced microfluidic collection, handling and transferring of fluids |
| US9950321B2 (en) | 2014-08-04 | 2018-04-24 | General Electric Company | Device for separation and collection of plasma |
| US10335078B2 (en) | 2014-08-04 | 2019-07-02 | General Electric Company | Device for separation and collection of plasma |
| EP3201350B1 (en) | 2014-09-30 | 2020-12-02 | Global Life Sciences Solutions USA LLC | Method for nucleic acid analysis directly from an unpurified biological sample |
| US10111610B2 (en) * | 2014-11-04 | 2018-10-30 | Wainamics, Inc. | Microscale plasma separator |
| US10287570B2 (en) * | 2014-11-21 | 2019-05-14 | Occam Biolabs, Inc. | System and method for collecting a sample of nucleic acid |
| US20180008183A1 (en) | 2015-01-28 | 2018-01-11 | Seventh Sense Biosystems, Inc. | Devices and methods for delivering and/or receiving fluid |
| US10597697B2 (en) | 2015-02-05 | 2020-03-24 | Ge Healthcare Bio-Sciences Corp. | Method of determining a nucleotide sequence of a nucleic acid segment from a region of interest in a biological sample |
| WO2016134324A1 (en) | 2015-02-20 | 2016-08-25 | Neoteryx, Llc | Method and apparatus for acquiring blood for testing |
| US9730625B2 (en) | 2015-03-02 | 2017-08-15 | Verily Life Sciences Llc | Automated blood sampling device |
| ES2903175T3 (es) | 2015-03-31 | 2022-03-31 | Hoffmann La Roche | Tarjeta de separación de plasma |
| CN107567306B (zh) | 2015-05-14 | 2020-06-26 | 通用电气公司 | 用于血浆的分离和收集的装置 |
| PL3097933T3 (pl) | 2015-05-26 | 2020-03-31 | F. Hoffmann-La Roche Ag | Kaseta i urządzenie wprowadzające dla układu medycznego |
| JP6558971B2 (ja) | 2015-06-17 | 2019-08-14 | 株式会社日立ハイテクノロジーズ | 採血装置 |
| KR102604091B1 (ko) | 2015-07-17 | 2023-11-22 | 큐 헬스 인코퍼레이티드 | 분석물질의 증진된 검출 및 정량을 위한 시스템 및 방법 |
| MX2018001352A (es) | 2015-08-06 | 2018-05-22 | Becton Dickinson Co | Dispositivo de recoleccion de fluido biologico y sistema de recoleccion de fluido biologico. |
| JP6940485B2 (ja) | 2015-08-28 | 2021-09-29 | クリシー メディカル システムズ インコーポレイテッド | 吸収体を備える流量センサシステム |
| WO2017044888A1 (en) | 2015-09-09 | 2017-03-16 | Theranos, Inc. | Methods and devices for sample collection and sample separation |
| CN108473932B (zh) | 2015-09-09 | 2022-07-15 | 集联健康有限公司 | 用于样品收集、稳定化和保存的系统、方法和装置 |
| EP3371326B1 (en) | 2015-11-05 | 2023-11-01 | Global Life Sciences Solutions Operations UK Ltd | Ligase-assisted nucleic acid circularization and amplification |
| US20170128934A1 (en) | 2015-11-10 | 2017-05-11 | Neoteryx, Llc | Plasma extraction device |
| EP3393342B1 (en) | 2015-12-21 | 2020-07-08 | Tasso, Inc. | Devices for actuation and retraction in fluid collection |
| WO2017139723A1 (en) | 2016-02-12 | 2017-08-17 | Perqflo, Llc | Ambulatory infusion pumps and assemblies for use with same |
| US10610862B2 (en) | 2016-04-04 | 2020-04-07 | Advance Dx, Inc. | Multiple path sample collection card |
| WO2017214338A1 (en) | 2016-06-07 | 2017-12-14 | Drawbridge Health, Inc. | Metods and devices for strong or stabilizing molecules |
| EP3490453B1 (en) | 2016-07-29 | 2021-12-01 | YourBio Health, Inc. | Device for receiving bodily fluid from a subject |
| US11523805B2 (en) | 2016-09-21 | 2022-12-13 | Tasso, Inc. | Methods for delivery of bodily fluids onto a fibrous substrate |
| TWI882519B (zh) | 2017-01-10 | 2025-05-01 | 美商集聯健康有限公司 | 用於收集和儲存來自受試者之血液的裝置 |
| CN107260186A (zh) | 2017-07-07 | 2017-10-20 | 深圳鹏博威投资控股有限公司 | 负压式采血针头 |
| USD870264S1 (en) | 2017-09-06 | 2019-12-17 | C. R. Bard, Inc. | Implantable apheresis port |
| JP7438137B2 (ja) | 2018-05-14 | 2024-02-26 | ループ メディカル エスアー | ユーザーの流体のサンプルを抽出および採取するためのサンプル採取デバイス、システム、および方法 |
| EP4278983A3 (en) | 2018-09-14 | 2023-12-20 | Tasso, Inc. | Bodily fluid collection device |
| ES2940212T3 (es) | 2019-11-13 | 2023-05-04 | Loop Medical Sa | Dispositivo de recogida de muestras para extraer y recoger una muestra de un fluido de un usuario |
| EP4121733A4 (en) | 2020-03-18 | 2024-05-22 | Drawbridge Health, Inc. | SAMPLE COLLECTION SYSTEMS AND METHODS |
-
2016
- 2016-09-09 CN CN201680065140.4A patent/CN108473932B/zh active Active
- 2016-09-09 CN CN202210755091.4A patent/CN115161178A/zh active Pending
- 2016-09-09 GB GB1615387.6A patent/GB2547062B/en active Active
- 2016-09-09 ES ES16845220T patent/ES2818569T3/es active Active
- 2016-09-09 FI FIEP22150560.5T patent/FI4035762T3/fi active
- 2016-09-09 EP EP16845220.9A patent/EP3347448B1/en active Active
- 2016-09-09 HK HK19100804.5A patent/HK1258397A1/zh unknown
- 2016-09-09 ES ES22150560T patent/ES2963004T3/es active Active
- 2016-09-09 GB GB2000728.2A patent/GB2578075B/en active Active
- 2016-09-09 EP EP20175443.9A patent/EP3754011B1/en active Active
- 2016-09-09 ES ES20175443T patent/ES2912965T3/es active Active
- 2016-09-09 US US15/261,707 patent/US11266337B2/en not_active Expired - Fee Related
- 2016-09-09 EP EP23189254.8A patent/EP4289356A3/en active Pending
- 2016-09-09 EP EP22150560.5A patent/EP4035762B1/en active Active
- 2016-09-09 JP JP2018512965A patent/JP7142569B2/ja active Active
- 2016-09-09 WO PCT/US2016/051157 patent/WO2017044887A1/en not_active Ceased
-
2022
- 2022-01-21 US US17/581,711 patent/US20220218251A1/en not_active Abandoned
- 2022-04-01 JP JP2022061959A patent/JP7330325B2/ja active Active
-
2023
- 2023-08-08 JP JP2023129537A patent/JP7454734B2/ja active Active
- 2023-08-11 US US18/233,283 patent/US20230380738A1/en not_active Abandoned
-
2024
- 2024-03-11 JP JP2024037159A patent/JP2024083344A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2818569T3 (es) | Métodos para la recopilación, estabilización y conservación de muestras | |
| US20250034618A1 (en) | Methods and devices for storing or stabilizing molecules | |
| JP6254117B2 (ja) | 制御された移転生体試料採取装置およびその装置を使用する方法 | |
| JP6695285B2 (ja) | 生物学的試料を採取して安定化するためのデバイス及び方法 | |
| US20160349156A9 (en) | Integrated Membrane for Preservation of Biomolecules | |
| US20210363514A1 (en) | Syringe-type nucleic acid extraction apparatus, nucleic acid extraction kit and nucleic acid extraction method therewith | |
| WO2018071296A1 (en) | Point of care isothermal diagnostic | |
| EP1382677B1 (en) | A method for separating and purifying RNA | |
| HK40079354A (en) | Systems, methods, and devices for sample collection, stabilization and preservation | |
| HK40081221A (en) | Systems, methods, and devices for sample collection, stabilization and preservation | |
| HK40043782A (en) | Devices for sample collection, stabilization and preservation | |
| HK40105685A (en) | Devices for sample collection, stabilization and preservation | |
| HK1242728A1 (en) | Systems, methods, and devices for sample collection, stabilization and preservation | |
| US20250176881A1 (en) | Devices for collecting biological samples | |
| JP6575945B2 (ja) | 固体生体試料の分析用試料ホルダ、生体試料収容カセット及び方法 | |
| JP2002345462A (ja) | 吸着バッファ及び核酸精製方法 |